Marksans Pharma Limited — Loratadine Exporter Profile
Indian Pharmaceutical Exporter · #3 for Loratadine · $7.9M export value · DGFT Verified
Marksans Pharma Limited is the #3 Indian exporter of Loratadine with $7.9M in export value and 339 verified shipments. Marksans Pharma Limited holds a 4.6% market share in Loratadine exports across 6 countries. The company exports 22 pharmaceutical products worth $125.0M across 11 therapeutic categories.
Marksans Pharma Limited — Loratadine Export Profile: Buyers & Destinations
Where Does Marksans Pharma Limited Export Loratadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $6.4M | 241 | 84.8% |
| UNITED STATES | $1.0M | 87 | 13.8% |
| AUSTRALIA | $55.4K | 11 | 0.7% |
| IRAQ | $24.2K | 3 | 0.3% |
| UNITED ARAB EMIRATES | $14.3K | 2 | 0.2% |
| CAMBODIA | $4.8K | 1 | 0.1% |
Marksans Pharma Limited exports Loratadine to 6 countries. The largest destination is UNITED KINGDOM accounting for 84.8% of Marksans Pharma Limited's Loratadine shipments, followed by UNITED STATES (13.8%) and AUSTRALIA (0.7%). These destinations reflect Marksans Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Loratadine from Marksans Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| RELONCHEM LTD | UNITED KINGDOM | $3.0M | 105 |
| RELONCHEM LTD CHESHIRE HOUSE, | UNITED KINGDOM | $2.4M | 101 |
| RELONCHEM LIMITED | UNITED KINGDOM | $660.8K | 19 |
| TIME-CAP LABS, | UNITED STATES | $534.8K | 39 |
| RELONCHEM LTD CHESHIRE HOUSE | UNITED KINGDOM | $241.8K | 7 |
| TIME CAP LABS | UNITED STATES | $149.3K | 9 |
| TIME-CAP LABS INC | UNITED STATES | $139.7K | 11 |
| RELONCHEM LIMITED CHESHIRE HOUSE | UNITED KINGDOM | $135.9K | 9 |
| TIME-CAP LABS, INC | UNITED STATES | $114.4K | 17 |
| TIME-CAP LABS | UNITED STATES | $75.4K | 6 |
Marksans Pharma Limited supplies Loratadine to 19 buyers globally. The largest buyer is RELONCHEM LTD (UNITED KINGDOM), followed by RELONCHEM LTD CHESHIRE HOUSE, (UNITED KINGDOM) and RELONCHEM LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Loratadine Export Value and How Much Does Marksans Pharma Limited Contribute?
India exported $49.6M worth of Loratadine through 4,321 shipments from 347 suppliers to 131 countries, serving 909 buyers globally. Marksans Pharma Limited contributes $7.9M to this total, accounting for 4.6% of India's Loratadine exports. Marksans Pharma Limited ships Loratadine to 6 countries through 19 buyers.
What Is the Average Shipment Value for Marksans Pharma Limited's Loratadine Exports?
Marksans Pharma Limited's average Loratadine shipment value is $23.4K per consignment, based on 339 shipments totaling $7.9M. The largest destination is UNITED KINGDOM (84.8% of Marksans Pharma Limited's Loratadine exports).
How Does Marksans Pharma Limited Compare to Other Indian Loratadine Exporters?
Marksans Pharma Limited ranks #3 among 347 Indian Loratadine exporters with a 4.6% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.8M), MARKSANS PHARMA LIMITED ($7.9M), SANDOZ PRIVATE LIMITED ($4.5M). Marksans Pharma Limited processed 339 shipments to 6 destination countries.
What Loratadine Formulations Does Marksans Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS-LORATADINE 10MG | $1.2M | 34 |
| LORATADINE LIQUID FILLED CAPSULES 10 MG | $412.3K | 34 |
| LORATADINE 10MG TABLETS Batch No: 130723 | $83.7K | 2 |
| LORATADINE 10MG TABLETS BATCH NO: 130093 | $80.9K | 2 |
| LORATADINE 10MG TABLETS BATCH NO: 130079 | $79.8K | 2 |
| PHARMACEUTICAL PRODUCTS - LORATADINE 10MG TABLETS BATCH NO: 140169140189NOS | $79.4K | 3 |
| PHARMACEUTICAL PRODUCTS - LORATADINE 10MG TABLETS Batch No: 142256 | $77.2K | 2 |
| PHARMACEUTICAL PRODUCTS - LORATADINE 10MG TABLETS Batch No: 150178 | $74.5K | 2 |
| PHARMACEUTICAL PRODUCTS - LORATADINE 10MG TABLETS BATCH NO: 140463 | $65.6K | 3 |
| PHARMACEUTICAL PRODUCTS - LORATADINE 10MG TABLETS BATCH NO: 140785 | $65.1K | 3 |
Marksans Pharma Limited exports 206 distinct Loratadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS-LORATADINE 10MG with 34 shipments worth $1.2M.
Regulatory Requirements: Exporting Loratadine to Key Markets
What Marksans Pharma Limited must comply with to export Loratadine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Marksans Pharma Limited Compare to Nearest Loratadine Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AUROBINDO PHARMA LTD | $10.8M | 265 | 5 | $40.9K |
| 3 | MARKSANS PHARMA LIMITED ★ | $7.9M | 339 | 6 | $23.4K |
| 1 | SANDOZ PRIVATE LIMITED | $4.5M | 89 | 5 | $50.0K |
| 4 | GRANULES INDIA LIMITED | $4.3M | 98 | 1 | $44.1K |
Marksans Pharma Limited ranks #3 among 347 Indian Loratadine exporters. Average shipment value of $23.4K compared to the market average of $142.8K. The closest competitors by value are AUROBINDO PHARMA LTD and SANDOZ PRIVATE LIMITED.
Which Indian Ports Ship Loratadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 584 | 13.5% |
| JNPT/ NHAVA SHEVA SEA | 312 | 7.2% |
| SAHAR AIR | 289 | 6.7% |
| JNPT | 252 | 5.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 227 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 198 | 4.6% |
| DELHI AIR | 183 | 4.2% |
| HYDERABAD ICD | 113 | 2.6% |
What Other Antihistamines & Allergy Products Does Marksans Pharma Limited Export?
Marksans Pharma Limited also exports these antihistamines & allergy products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Marksans Pharma Limited's Loratadine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Marksans Pharma. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, a crucial maritime route for trade between Asia and Europe. Major shipping lines have introduced an 'Emergency Risk Surcharge' ranging from $250 to $500 per TEU for cargo transiting the Bab-el-Mandeb Strait, effective February 2025. This surcharge elevates shipping costs, potentially impacting the competitiveness of Indian pharmaceutical exports to European and US East Coast markets. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (FTA), concluded in January 2026, offers a silver lining. The FTA eliminates tariffs on Indian pharmaceuticals, APIs, vaccines, and medical devices, providing immediate cost relief and enhancing market access for Indian exporters. This development positions Marksans Pharma favorably to increase its footprint in the European market, leveraging its existing regulatory approvals and manufacturing capabilities. (en.wikipedia.org)
Marksans Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for pharmaceutical exporters. Marksans Pharma has demonstrated a strong commitment to regulatory compliance. In November 2025, the company's Goa facility underwent a current Good Manufacturing Practice (cGMP) inspection by the US FDA, concluding with zero Form 483 observations. This outcome reflects Marksans' dedication to adhering to international quality standards and regulatory requirements. (capitalmarket.com)
Furthermore, the company's subsidiaries have achieved significant regulatory milestones. Time-Cap Laboratories Inc., Marksans' US subsidiary, received an Establishment Inspection Report (EIR) from the US FDA for its New York-based facility in June 2025, following an inspection that resulted in only one observation with no data integrity issues. Such achievements bolster Marksans' reputation as a reliable and compliant pharmaceutical manufacturer. (business-standard.com)
About Marksans Pharma Limited
Marksans Pharma Limited exports 22 products worth $125.0M. Beyond Loratadine, top products include Ibuprofen, Amino, Gabapentin, Acetaminophen, Cetirizine. View the complete Marksans Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Loratadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Loratadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Marksans Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 345 individual customs records matching Marksans Pharma Limited exporting Loratadine, covering 206 formulations to 6 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 909+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Loratadine Export Data from Marksans Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Marksans Pharma Limited's Loratadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Marksans Pharma Limited
Full Company Profile →
22 products · $125.0M total trade · 11 categories
Loratadine Stats
Company Overview
Top Products by Marksans Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Marksans Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Loratadine. For current shipment-level data, contact TransData Nexus.